Bio-Alcamid complications: A 10 year review

Area of Science:

• Dermatology and Aesthetic Medicine
• Biomaterials Science
• Infectious Disease Management

Background:

• This study revisits patients previously treated with polyalkimide gel (Bio-Alcamid) for HIV-associated lipoatrophy.
• It serves as a 10-year extended follow-up to an earlier report on early and late complications.

Discussion:

• Focuses on the spectrum and incidence of late-onset complications associated with Bio-Alcamid.
• Evaluates the long-term safety profile of polyalkimide gel in facial reconstruction for HIV lipoatrophy.
• Analyzes the clinical course and management of delayed adverse events.

Key Insights:

• Polyalkimide gel can lead to significant late complications years after initial treatment for HIV lipoatrophy.
• The 10-year follow-up highlights the persistent risk of adverse events, necessitating ongoing patient monitoring.
• Understanding these late-onset complications is crucial for informed patient selection and management strategies.

Outlook:

• Further research is needed to elucidate the mechanisms behind late polyalkimide gel complications.
• Development of improved biomaterials or alternative treatments for HIV lipoatrophy may be warranted.
• Long-term surveillance protocols for patients receiving aesthetic fillers are essential.